amiral
Posted - 23 hours ago
@Smoothoperator99 @Stocktor Hey dude, you don’t @Stocktor and I am not here and will never lick anybody’s ass. One thing I can tell about him is that he have made really good calls and he have really good expertise especially in biopharmas. I rode $CCXI with him and we made bunch of money. Because of his call I made 5x of my investment.
He also called other for example $DRCT when it was at $2 and then it run up to $34.
So if you seriously don’t know him don’t bash him. You make yourself like an idiot when you post stupid posts like these.
Be sensible and reasonable.
Steve_TheBull_Rogers
Posted - 4 days ago
@Mitxu Examples $CCXI and $LABP Both i was in, both pre market PR to say being bought, x amount, term of deal and closing date
Night_Owl_Biotech
Posted - 1 week ago
$BCRX 's enterprise value ("EV") is 17% of total 10-year analyst consensus revenue estimates. This is roughly half the revenue multiples of peers $PRVB, $CCXI, $GBT & $GWPH when they were acquired (EV's at 32 to 38% of their respective total 10-year revenue estimates per management...as filed in the subsequent 14A/14D9 filings). BCRX's gross margins are higher than all 4. Because BCRX is leveraged, BCRX's market cap would be roughly 150% higher if acquired at these peer revenue multiples (BCRX debt data per Seeking Alpha). BCRX's debt obligations may be higher if liquidated. It has been 41 months since Orladeyo was approved. GBT & GWPH were acquired roughly 33 months after FDA approval. These data points are summarized on the attachment. This is not investment advice. We're only pointing out the math associated with this BCRX "what if." As always, it is also possible our math is wrong. We suggest you research for yourself.
martindube
Posted - 2 weeks ago
$CCXI got me the black S6. Not really worried about $TRKAQ and my RS7
RamenLives
Posted - 03/28/24
$CCXI $60
Steve_TheBull_Rogers
Posted - 03/27/24
$AKBA Just took a call with a friend in pharma. He said the likelihood is that sooner or later, CSL VIFOR will buy this out for a tender + additional share in their bio per count
It's now a play like $CCXI
Dmoney136
Posted - 03/27/24
$AKBA friendly reminder that $CCXI did the same thing before approval.
Anxietyy
Posted - 03/27/24
@Steve_TheBull_Rogers you remember the dip of $CCXI
Dmoney136
Posted - 03/27/24
@Stockinvestor73 this was $CCXI before approval. Nice try.
Dmoney136
Posted - 03/27/24
$AKBA this was $CCXI
Dmoney136
Posted - 03/27/24
$AKBA stop loss raid, I remember $CCXI was crazy, dropped from 30 to like 22 and rebound within a few minutes.
Steve_TheBull_Rogers
Posted - 03/27/24
$AKBA So you've prob clocked a lot of shorts follow me and come into the bio plays on long in, One is here and you've prob noticed him. I actually welcome it as their short causes more to squeeze in binary event I had one reach out to me over a year ago to say he kept shorting $CCXI as I was long and he hated me, he kept shorting even after approval when it had move 20 bucks, he then got caught short on the buy out He lost his whole account. So shorts who follow me, welcome, the water is warm
Grrrissom
Posted - 4 weeks ago
@DailyStocksPicks "The sharp decline...is predominantly attributed to concerns...regarding a higher incidence of EARLY DEATHS in patients treated?!!" Sure not getting the same vibe from this as I did that made me buy $CCXI when an advisory panel got involved.
printintendies
Posted - 1 month ago
$AKBA they did a stop loss raid in AH the day before avacopan was approved for $CCXI. Expect the unexpected. If you expect it it’s not unexpected 😂
NCpilot172
Posted - 1 month ago
@SPECTRAL1 SA is a joke. I remember a couple of months before $CCXI was bought out, they were running hit pieces along with tipranks bashing the company. The arguments were invalid and highly biased, not objective and true. I would never take any article seriously. You never know what the authors hidden motives are. Always trust your own DD and trust it only!
Ohzipit
Posted - 1 month ago
@eriklarsen my DD is just fine. $VKTX @ $10, $RNA @ $6, $CBAY @$8, $CCXI $14 I can go on and on.
Call_Me_Put
Posted - 1 month ago
$GERN A $1.5/$2 4/19 strangle could be a decent play. IV is way too high on weeklies. I also like the drugs odds at approval and will pick up some shares if the ADCOM recommends against approval. Last post-ADCOM clinical bio play I made was $CCXI. ADCOM voted against, stock dropped around 80%, gladly bought some shares and the FDA approved it six months later. Advisory committees are typically way more cautious than the FDA itself, just remember that.
StillnessofBreath
Posted - 1 month ago
$MCRB shares are being stolen! https://link.springer.com/article/10.1007/s40265-024-02006-7
Everyone loves to say ATM, but no one has a clue,ostensibly don’t read 10q
1. If atm, still super undervalued, at least you aren’t buying at $5
Either way this is more like $CCXI $PRVB where they dropped heavily after approval to accumulate before buyout announcement
RamenLives
Posted - 1 month ago
$CCXI Not try to plug anything, just looking for some feedback on what you CCXI veterans think of $AADI...
Ohzipit
Posted - 02/27/24
@harri_28 hang in there. Same analyst covers both at RJF. Has a strong buy rating and a price target of $50. He also covered $CBAY (just bought) and $CCXI (bought by $AMGN in 2022.
benderok37
Posted - 2 months ago
$IFRX Market cap 80millions. In 2021, $AGEN paid $3.7 billions for $CCXI (Avacopan) How true is
RamenLives
Posted - 2 months ago
$IOVA feels like the day after the $ccxi approval...maybe we will see a crazy sp...something in the twenties???
NCpilot172
Posted - 2 months ago
$CCXI Doing some work, look what popped up. Good ole Tavneos…..
spyzinger
Posted - 2 months ago
$VRNA This is exactly what happened in $CCXI as well prior to approval. Right about the same price too,
newdmontheblock
Posted - 2 months ago
@Cchan78 @Nikki7220 back when $CCXI was approved, their PR dropped Friday morning. No reason we can’t here either
PotatoJoe
Posted - 2 months ago
$CCXI What have we learned after more than a year and a half since the buyout? That buyouts are as rare as seeing a Joe Biden diaper accident in the news.
Ohzipit
Posted - 2 months ago
$RNA thought I would repost this most current RJF research dated 0/05/24.
Strong Buy rated price target $71.00. Same analyst gave us $CCXI and $CBAY
NEWBIGTECH
Posted - 2 months ago
@Scooter0732 $ICU $ESPR $FEMY these 3 stocks should be winners this year. I have been in chat for years. Bought $CBAY and $CCXI same day and same year.
NEWBIGTECH
Posted - 2 months ago
$THAR This stock reminds me of $CBAY and $CCXI when I bought both. It has answers to disease management.
Steve_TheBull_Rogers
Posted - 2 months ago
$MCRB Who was in the $CCXI buy out with me? Had months of just up down up down then one morning news hit and we gapped up the buy out This and AMRN are my two BO targets of 2024 Im sure this one will be gone before Q2 finishes